29/07/2025 (Agence Europe) – On Monday 28 July, the European Federation of Pharmaceutical Industries and Associations (EFPIA) expressed its concerns about the trade agreement between the European Union and the United States, which at this stage leaves the pharmaceutical sector in a state of uncertainty when it comes to tariffs (see other news). “Tariffs on medicines are a blunt instrument that will disrupt supply chains, impact on investment in research and development, and ultimately...